Mayo explains findings from a pooled analysis of pruritus data from RESPONSE and ENHANCE highlighting seladelpar’s impact on itch in PBC.
Marlyn Mayo, MD
Advertisement
Marlyn Mayo, MD, is a professor of internal medicine at UT Southwestern Medical Center.
Articles by Marlyn Mayo, MD
Mayo explains current shortcomings of pruritus care in PBC and what the additions of elafibranor, seladelpar, and other agents in development may offer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD
2
Navigating Emotional Burden in IBD
3
Linaclotide in Pediatric IBS-C—Evidence, Indications, and Practical Use
4
Open Communication Between Patients and Providers in IBD
5